| Product Code: ETC12320170 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Hormone Refractory Prostate Cancer Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Hormone Refractory Prostate Cancer Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Hormone Refractory Prostate Cancer Market - Industry Life Cycle |
3.4 South Korea Hormone Refractory Prostate Cancer Market - Porter's Five Forces |
3.5 South Korea Hormone Refractory Prostate Cancer Market Revenues & Volume Share, By Cancer Stage, 2021 & 2031F |
3.6 South Korea Hormone Refractory Prostate Cancer Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 South Korea Hormone Refractory Prostate Cancer Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 South Korea Hormone Refractory Prostate Cancer Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 South Korea Hormone Refractory Prostate Cancer Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and early diagnosis of hormone refractory prostate cancer in South Korea |
4.2.2 Advancements in treatment options and technologies for managing the disease |
4.2.3 Growing prevalence of prostate cancer among the aging population in South Korea |
4.3 Market Restraints |
4.3.1 High cost associated with advanced treatment modalities for hormone refractory prostate cancer |
4.3.2 Limited access to specialized healthcare facilities and expertise in managing the disease |
4.3.3 Regulatory challenges and approval processes for new therapies in the South Korean market |
5 South Korea Hormone Refractory Prostate Cancer Market Trends |
6 South Korea Hormone Refractory Prostate Cancer Market, By Types |
6.1 South Korea Hormone Refractory Prostate Cancer Market, By Cancer Stage |
6.1.1 Overview and Analysis |
6.1.2 South Korea Hormone Refractory Prostate Cancer Market Revenues & Volume, By Cancer Stage, 2021 - 2031F |
6.1.3 South Korea Hormone Refractory Prostate Cancer Market Revenues & Volume, By Castration-resistant Prostate Cancer, 2021 - 2031F |
6.1.4 South Korea Hormone Refractory Prostate Cancer Market Revenues & Volume, By Metastatic Hormone-refractory Cancer, 2021 - 2031F |
6.1.5 South Korea Hormone Refractory Prostate Cancer Market Revenues & Volume, By Non-metastatic Hormone-refractory Cancer, 2021 - 2031F |
6.1.6 South Korea Hormone Refractory Prostate Cancer Market Revenues & Volume, By Recurrent Prostate Cancer, 2021 - 2031F |
6.2 South Korea Hormone Refractory Prostate Cancer Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 South Korea Hormone Refractory Prostate Cancer Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.2.3 South Korea Hormone Refractory Prostate Cancer Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.2.4 South Korea Hormone Refractory Prostate Cancer Market Revenues & Volume, By Androgen Receptor Inhibitors, 2021 - 2031F |
6.2.5 South Korea Hormone Refractory Prostate Cancer Market Revenues & Volume, By Radioisotope Therapy, 2021 - 2031F |
6.3 South Korea Hormone Refractory Prostate Cancer Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 South Korea Hormone Refractory Prostate Cancer Market Revenues & Volume, By Men Aged 50+, 2021 - 2031F |
6.3.3 South Korea Hormone Refractory Prostate Cancer Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.3.4 South Korea Hormone Refractory Prostate Cancer Market Revenues & Volume, By Urology Clinics, 2021 - 2031F |
6.3.5 South Korea Hormone Refractory Prostate Cancer Market Revenues & Volume, By Cancer Research Institutes, 2021 - 2031F |
6.4 South Korea Hormone Refractory Prostate Cancer Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 South Korea Hormone Refractory Prostate Cancer Market Revenues & Volume, By Late-stage Cancer Treatment, 2021 - 2031F |
6.4.3 South Korea Hormone Refractory Prostate Cancer Market Revenues & Volume, By Advanced Prostate Cancer Care, 2021 - 2031F |
6.4.4 South Korea Hormone Refractory Prostate Cancer Market Revenues & Volume, By Localized Prostate Cancer, 2021 - 2031F |
6.4.5 South Korea Hormone Refractory Prostate Cancer Market Revenues & Volume, By Precision Oncology, 2021 - 2031F |
7 South Korea Hormone Refractory Prostate Cancer Market Import-Export Trade Statistics |
7.1 South Korea Hormone Refractory Prostate Cancer Market Export to Major Countries |
7.2 South Korea Hormone Refractory Prostate Cancer Market Imports from Major Countries |
8 South Korea Hormone Refractory Prostate Cancer Market Key Performance Indicators |
8.1 Average age of diagnosis for hormone refractory prostate cancer patients in South Korea |
8.2 Rate of adoption of novel treatment modalities in the market |
8.3 Number of clinical trials and research studies focused on hormone refractory prostate cancer in South Korea |
9 South Korea Hormone Refractory Prostate Cancer Market - Opportunity Assessment |
9.1 South Korea Hormone Refractory Prostate Cancer Market Opportunity Assessment, By Cancer Stage, 2021 & 2031F |
9.2 South Korea Hormone Refractory Prostate Cancer Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 South Korea Hormone Refractory Prostate Cancer Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 South Korea Hormone Refractory Prostate Cancer Market Opportunity Assessment, By Application, 2021 & 2031F |
10 South Korea Hormone Refractory Prostate Cancer Market - Competitive Landscape |
10.1 South Korea Hormone Refractory Prostate Cancer Market Revenue Share, By Companies, 2024 |
10.2 South Korea Hormone Refractory Prostate Cancer Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here